Exacerbation of Secondary Cold Agglutinin Syndrome in the Setting of SARS-CoV-2.

autoimmune hemolytic anemia (aiha) cold agglutinin syndrome covid coagulopathy covid hypercoagulability covid-19 covid-19 associated coagulopathy covid-19 pneumonia sars-cov-2 severe acute respiratory syndrome coronavirus-2 (sars-cov-2) transfusion in covid 19 pandemic

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Nov 2021
Historique:
accepted: 09 11 2021
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 21 12 2021
Statut: epublish

Résumé

In this report, we present a case of exacerbation of cold agglutinin syndrome (CAS) potentially due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. An 83-year-old female with a history of cold agglutinin hemolytic anemia presented with shortness of breath, productive cough, worsening orthopnea, darkening fingers and urine, and jaundice. Laboratory investigations found elevated white blood cells (WBC) and total bilirubin, severely low hemoglobin, and positive direct Coombs test. Moreover, SARS-CoV-2 RNA was also found to be positive in a sample from the nasal swab by reverse transcription-polymerase chain reaction (RT-PCR), indicating exacerbation of CAS secondary to viral coronavirus 2019 (COVID-19) infection. A treatment regime for SARS-CoV-2 consisting of five days of remdesivir and seven days of dexamethasone 6 mg IV was initiated, resulting in significant improvement in the patient's condition.

Identifiants

pubmed: 34925989
doi: 10.7759/cureus.19387
pmc: PMC8655486
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e19387

Informations de copyright

Copyright © 2021, Bhagat et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Blood. 1977 Aug;50(2):195-202
pubmed: 194643
Front Immunol. 2020 Apr 07;11:590
pubmed: 32318071
BMJ Case Rep. 2021 Jul 26;14(7):
pubmed: 34312140
Clin Case Rep. 2020 Jul 20;:
pubmed: 32837721
Clin Infect Pract. 2020 Oct;7:100041
pubmed: 32924007
Br J Haematol. 2020 Aug;190(4):e183-e184
pubmed: 32460350
J Blood Med. 2021 Aug 31;12:785-793
pubmed: 34512059
Clin Hematol Int. 2020 Jul 17;2(3):95-100
pubmed: 34595449
Med Clin (Engl Ed). 2021 Oct 22;157(8):388-394
pubmed: 34632064
Thromb Res. 2020 Oct;194:101-115
pubmed: 32788101
Clin Adv Hematol Oncol. 2020 Jan;18(1):35-44
pubmed: 32511221
Br J Haematol. 2018 May;181(3):320-330
pubmed: 29363757
Eur J Epidemiol. 1997 Jul;13(5):581-6
pubmed: 9258572

Auteurs

Yash V Bhagat (YV)

Internal Medicine, University of Maryland Midtown Campus, Baltimore, USA.
College of Medicine, American University of Antigua, St. John's, ATG.

Siham Hussien (S)

Internal Medicine, University of Maryland Midtown Campus, Baltimore, USA.

Helen Queenan (H)

Internal Medicine, Howard University College of Medicine, Washington, D.C., USA.

Miriam B Michael (MB)

Internal Medicine, Howard University College of Medicine, Washington, D.C., USA.
Internal Medicine, University of Maryland Midtown Campus, Baltimore, USA.

Classifications MeSH